Download Brochure
Table of Content
Get a Price
March 2025
.webp)
Principal Consultant
Reviewed By
The U.S. patient monitoring devices market size is calculated at USD 21.4 billion in 2024, grew to USD 23.03 billion in 2025, and is projected to reach around USD 44.68 billion by 2034. The market is expanding at a CAGR of 7.64% between 2025 and 2034. The rising prevalence of chronic disorders and technological advancements drive the market.
The global market for patient monitoring devices is experiencing steady growth. In 2024, it's valued at about $59.36 billion and is expected to rise to $63.94 billion in 2025. Looking ahead, the market is projected to nearly double, reaching around $123.72 billion by 2034. This growth, at an annual rate of 7.73% from 2025 to 2034, is fueled by advancements in medical technology, a booming medical device industry, and an increasing focus on preventive healthcare services.
Patient monitoring devices are tools that measure patients' vital signs to help healthcare professionals make informed decisions. These devices can monitor and analyze parameters such as blood pressure, blood glucose levels, temperature, weight, and heart rate. They help patients engage and better understand their health daily. They augment in-person care, allowing healthcare professionals to recognize the full picture of their patients’ symptoms over time. There are several types of patient monitoring devices, including basic vital sign monitors, advanced multi-parameter monitors, fetal monitors, and remote patient monitoring (RPM) devices. These devices provide efficient patient care and aid in early disease detection.
The rising incidence and prevalence of chronic disorders, such as cardiovascular disorders and metabolic diseases, boost the market. The growing demand for personalized patient care facilitates the use of patient monitoring devices. Technological advancements drive the latest innovations in patient monitoring devices, augmenting the market. Favorable government policies and initiatives also support the market. Numerous government and private organizations provide sufficient funding for developing novel patient monitoring devices.
Artificial intelligence (AI) and machine learning (ML) algorithms have been proven to play a vital role in patient monitoring devices. They introduce automation in devices, promoting continuous remote monitoring. They enable real-time tracking of patients’ conditions, allowing providers to make proactive clinical decisions. They can also analyze vast amounts of patient data, helping healthcare professionals provide personalized treatment. Recent increases in computational speed have also led to the development of artificial neural networks and deep learning to handle and optimize complex datasets. AI can also alleviate or reduce complications in disease progression. Hence, AI and ML are incorporated into patient monitoring devices for early disease detection, personalized monitoring, and adaptive learning.
Demand for Remote Patient Monitoring
The major growth factor of the U.S. patient monitoring devices market is the growing demand for remote patient monitoring (RPM). The demand is increasing due to the rising geriatric population and the need for home healthcare. There were 58 million Americans aged 65 years or older in 2022, and this number is projected to reach 82 million by 2050. The geriatric population is also more prone to developing chronic disorders that necessitate the use of patient monitoring devices. Several companies manufacture RPM devices to provide personalized care and measure essential disease parameters in the comfort of their homes. The different types of RPM devices include wearable devices, mobile apps, and telehealth video conferencing. IQVIA estimated that by 2030, more than 142 million patients in the U.S., accounting for 40% of the total population, would be using RPM technology.
Privacy & Security Concerns
The major challenge faced by the market is the privacy & security concerns for patient monitoring devices. Privacy & security risks include unauthorized access, data breaches, and device manipulation. This leads to increased theft, fraud, or other malicious activities. Integration of AI and ML increases the chances of privacy & security concerns in patient monitoring devices, restricting market growth.
Latest Innovations
The future of the U.S. patient monitoring devices market is promising, driven by the latest innovations in patient monitoring devices. The growing research and development activities and increasing investments favor technological advancements. Researchers have identified the significance of microfluidic patches in providing real-time analysis of bodily biomarkers via a small adhesive patch. These patches reduce the need for painful, invasive tests, enhancing diagnostic accuracy and improving patient engagement. Apart from microfluidic patches, epidermal technology has emerged as another continuous health monitoring technique. Additionally, the advent of sensors aids in continuous monitoring, reducing manual errors. Sensor-embedded smart fabrics provide non-intrusive health tracking, improving patient care and enriching health insights. Such latest innovations create ample opportunities for healthcare professionals and patients in the future, providing enhanced care.
By product, the multi-parameter monitoring devices segment held a dominant presence in the U.S. patient monitoring devices market in 2024. Multi-parameter monitoring devices can monitor ECG, respiration rate, blood pressure, temperature, and oxygen simultaneously in the same device. They are widely used in ICUs, hospitals, and emergency rooms. The increasing number of surgeries potentiate the use of multi-parameter monitoring devices. It is projected that around 12 to 21.4 operations are conducted per 100,000 people in the U.S. The device enables real-time signal processing and sends alerts to healthcare staff. They also distribute radiological data and monitor various life support systems.
By product, the cardiac monitoring devices segment is anticipated to show lucrative growth in the U.S. patient monitoring devices market during the forecast period. Cardiac monitoring devices enable the monitoring of ECG, blood pressure, and oxygen. The rising prevalence of cardiovascular disorders and other related disorders boosts the segment’s growth. According to the American Heart Association, a person dies every 34 seconds in the U.S. due to cardiovascular disease. Also, nearly 47% of U.S. adults have high blood pressure. These data necessitate the use of patient monitoring devices to track real-time data of patients, enabling healthcare professionals to make informed decisions. According to a survey conducted by The Ohio State University Wexner Medical Center on 1,008 Americans, around two-thirds use a device regularly to monitor their heart health.
By end-use, the hospital segment held the largest share of the U.S. patient monitoring devices market in 2024. The segmental growth is attributed to suitable capital investment, favorable infrastructure, and the presence of skilled professionals. Suitable capital investment allows hospitals to install novel and more advanced patient monitoring devices. The growing number of hospitals in the U.S. increases the demand for these devices. American Hospital Association surveyed that there were 6,093 hospitals in the U.S. as of 2023. The increasing number of hospitalizations due to severe acute and chronic conditions also augments the segment’s growth.
By end-use, the home care settings segment is anticipated to grow with the highest CAGR in the U.S. patient monitoring devices market during the studied years. The rising geriatric and working population in the U.S. increases the demand for home healthcare, eliminating the need to physically visit a healthcare setting. There are more than 170.7 Americans employed in the U.S. as of January 2025. The advent of wearable devices and AI-based sensors has also led to the use of remote patient monitoring devices. Several government organizations have launched initiatives and policies for screening and early detection of the disease.
Several factors govern the U.S. patient monitoring devices market, including the rising incidence and prevalence of chronic disorders and technological advancements. According to the Centers for Disease Control and Prevention, approximately 129 million Americans have at least one chronic disorder. The increasing healthcare expenditure also contributes to the market. The U.S. healthcare spending reached $4.9 trillion in 2023, accounting for $14,570 per person. Favorable government policies and regulatory frameworks also fuel the market. Approximately 188 companion diagnostic devices have been approved or cleared by the U.S. Food and Drug Administration (FDA) as of March 2025. The growing demand for personalized care fosters the market.
For instance,
Dr. Patrick Soon-Shiong, CEO of AirStrip, commented that their collaboration with GE Healthcare is a commitment to much deeper integration between their exceptional patient monitoring and their mobile and web clinical surveillance. The partnership would be able to offer a joint solution that empowers clinical teams to receive clinical and vital signs information remotely and effectively deal with constraints on clinical resources, enhancing clinicians’ user experiences.
By Product
By End-Use
March 2025
March 2025
March 2025
March 2025
Schedule a Meeting